This is a delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to IIT Research Institute (IITRI), a non-profit contract research organization. The $1,259,678.78 contract is to provide support for the preclinical development of an endoxifen gel, including pharmacology, toxicology, and safety studies to support an Investigational New Drug (IND) application. This contract is part of the NCI's PREVENT...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to the University of Alabama at Birmingham (UAB) for a randomized, single-blind safety and efficacy study of a vaginal gel or insert called TOL-463 in the treatment of vaginitis. The contract has a ceiling value of $2,076,810.82 and a completion date of November 30, 2017. There is no set-aside designation for this...
The National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $176,019 delivery order to the Albert Einstein College of Medicine, a private non-profit educational institution, to perform services related to the Ovaprene Vaginal Device clinical trial. The contract, which has no set-aside designation, covers protocol finalization, regulatory approval, start-up, and commencement of recruitment,...
This is a federal contract award to The Trustees of Columbia University in the City of New York, operating as the Health Sciences Division, by the National Institute of Child Health and Human Development (NICHD), a component of the U.S. Department of Health and Human Services. The contract is for a randomized controlled clinical trial to study the efficacy, safety, and acceptability of a female contraceptive product called C31G. The contract has a ceiling value of $902,337.00 and was awarded...
This federal contract award was issued by the National Institute of Child Health and Human Development (NICHD), a component of the National Institutes of Health (NIH), to Magee-Womens Research Institute And Foundation, a non-profit research organization. The $770,698 delivery order contract is part of the NICHD Contraceptive Clinical Trials Network and supports an open-label trial on the efficacy, cycle control, and safety of a contraceptive vaginal ring delivering a daily dose of Nestorone...
This is a delivery order awarded under the National Institute of Child Health and Human Development's "Nonclinical Contraceptive Vaginal Gel Development Services" Indefinite Delivery, Indefinite Quantity (IDIQ) contract. The $775,022.00 cost-plus-fixed-fee order was awarded to the non-profit research institute SRI International to provide research and development services related to a novel non-hormonal contraceptive vaginal gel. The order includes a subcontract with Mississippi...
This is a federal contract award from the National Institute of Child Health and Human Development (NICHD) to the Magee-Womens Research Institute And Foundation, a non-profit research organization focused on women's health. The $183,306 contract is for a Phase 1 clinical trial of the Ovaprene vaginal contraceptive device. This award is a delivery order under the $5 million IDIQ contract the institute holds with NICHD to participate in the Contraceptive Clinical Trials Network. The contract has...
The Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development awarded a $1,099,997.00 cost plus fixed fee delivery order contract to Sri International for Biological Testing Facility Task Order 15 - Nonclinical Female Contraceptive Development Services. The objective of this task order is to obtain nonclinical female contraceptive development services to determine, as appropriate, the safety and efficacy of candidate...
This federal contract award was issued by the National Institute of Child Health and Human Development (NICHD), a component of the National Institutes of Health (NIH), to the non-profit organization Essential Access Health (doing business as Cfhc). The $730,541.42 cost-no-fee delivery order is for a Female Contraceptive Clinical Trial: Vaginal Ring. The award has no set-aside designation. This delivery order is part of a broader indefinite delivery contract (IDC) with a potential value of $5...
This is a Delivery Order under Contract 75N94020D00004 awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Boston Medical Center Corporation (BMC) for a clinical trial of the OVAPRENE vaginal device. The award has a ceiling value of $126,095 and a period of performance through November 30, 2025. The contract is for TASK ORDER 2: OVAPRENE PHASE 1 - PROTOCOL FINALIZATION, PROCUREMENT OF REGULATORY APPR. BMC is a major safety-net hospital and...